It is with deep sadness that we announce our dear friend and colleague Torsten Goesch passed away unexpectedly earlier this week. Torsten was a highly respected member of the Rosetta team and he is much missed. Our thoughts and condolences go out to Torsten's family during this difficult time.
Pharmaceutical
Aprea’s mission is to be the leading player in the development and commercialization of p53-targeted cancer therapies.
Aprea Therapeutics is a biopharmaceutical company focused on developing and commercializing novel cancer therapeutics targeting DNA damage reponse (DDR) pathways.
CEO
Oren Gilad, PhD
Pharmaceutical
Massachusetts, USA
Registered in England No. 3941653 | VAT No. GB 765 3567 96
© 2017 Rosetta Capital Limited | Authorised and regulated by the Financial Conduct Authority
